Stockreport

IMUNON Receives $1.3 Million from Sale of its New Jersey Net Operating Losses [Yahoo! Finance]

Imunon, Inc.  (IMNN) 
PDF LAWRENCEVILLE, N.J., March 25, 2024 (GLOBE NEWSWIRE) -- IMUNON , Inc. (NASDAQ: IMNN) , a clinical-stage drug-development company focused on developing DNA-mediated immu [Read more]